Texas Attorney General Takes Legal Action Against Tylenol Manufacturers Regarding Autism Spectrum Allegations

Judicial Proceedings
The Texas Attorney General, a Trump ally who is running for US Senate, claimed the drug companies of withholding the risks of Tylenol

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the corporations concealed alleged dangers that the medication created to pediatric cognitive development.

This legal action follows a month after President Donald Trump promoted an unproven link between using Tylenol - also known as paracetamol - during pregnancy and autism in offspring.

The attorney general is taking legal action against J&J, which formerly manufactured the drug, the exclusive pain medication recommended for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "betrayed America by gaining financially from pain and marketing drugs regardless of the potential hazards."

The company states there is lacking scientific proof connecting acetaminophen to autism.

"These companies lied for decades, knowingly endangering numerous people to increase profits," the attorney general, from the Republican party, stated.

The company said in a statement that it was "very worried by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the well-being of women and children in America."

On its official site, the company also stated it had "consistently assessed the pertinent research and there is insufficient valid information that indicates a proven link between taking paracetamol and autism spectrum disorder."

Organizations representing medical professionals and medical practitioners concur.

The leading OB-GYN organization has said acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to treat discomfort and fever, which can create serious health risks if left untreated.

"In more than two decades of studies on the use of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the use of acetaminophen in any stage of pregnancy results in brain development issues in offspring," the group stated.

The court filing mentions current declarations from the former administration in asserting the medication is potentially dangerous.

In recent weeks, the former president generated worry from public health officials when he instructed expectant mothers to "resist strongly" not to consume acetaminophen when ill.

Federal regulators then released a statement that medical professionals should contemplate reducing the usage of Tylenol, while also declaring that "a direct connection" between the drug and autism in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in April to conduct "comprehensive study program" that would establish the cause of autism spectrum disorder in a matter of months.

But authorities cautioned that discovering a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism is a form of permanent neurological difference and impairment that influences how people experience and engage with the environment, and is diagnosed using doctors' observations.

In his legal document, the attorney general - who supports Trump who is running for US Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the science" around acetaminophen and autism.

This legal action aims to force the companies "destroy any commercial messaging" that states acetaminophen is safe for women during pregnancy.

This legal action parallels the grievances of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in 2022.

Judicial authorities threw out the lawsuit, declaring research from the plaintiffs' authorities was not conclusive.

Michael Hunter
Michael Hunter

A tech enthusiast and journalist with over a decade of experience covering emerging technologies and digital transformations.